Study to Assess the Effect of Food on the Pharmacokinetics of CA-4948 in Healthy Male Subjects
Phase 1
- Conditions
- Hematologic malignanciesMedDRA version: 20.0Level: HLTClassification code: 10003817Term: Blood autoimmune disorders Class: 10021428Therapeutic area: Diseases [C] - Hemic and Lymphatic Diseases [C15]
- Registration Number
- CTIS2023-509691-41-00
- Lead Sponsor
- Curis Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Male
- Target Recruitment
- 14
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: ;Secondary Objective: ;Primary end point(s):
- Secondary Outcome Measures
Name Time Method